Harmful rules in the Trans-Pacific Partnership (TPP) trade deal will mean people in developing countries will have less access to lifesaving medicines.

More >

MSF testifies in Congress on India's right to keep lifesaving medicines affordable.

More >

On Monday, December 19, Johnson & Johnson is expected to announce whether it intends to license its patents on three lifesaving HIV/AIDS drugs to the Medicines Patent Pool, a mechanism designed to lower prices of HIV medicines and increase access to them for people in the developing world.

More >

An Indian court has stopped the international pharmaceutical company Bayer?s latest attempt to introduce new measures to prevent generic competition in India.

More >

Human African Trypanosomiasis, also known as African Sleeping Sickness, is a fatal and much neglected disease that continues to plague parts of Africa. The drug most commonly used to treat the disease is so toxic that it kills one in 20 patients. While a better drug exists, it is too complex to use in resource-poor settings. In the Democratic Republic of Congo (DRC), sleeping sickness has made a disturbing comeback over the past few decades.

More >

Caring for children with HIV/AIDS is charged with obstacles. The struggle begins with doctors not being able to tell whether antibodies found in a small baby's blood are from the mother or whether they suggest the child itself is infected with the virus. Frustrated with the situation, MSF has been cooperating with scientists working on a new technology.

More >